FDA will consider OTC status for Sanofi allergy drug

Sanofi's prescription allergy nasal spray Nasacort "has a favorable risk-benefit profile," according to an FDA approval panel. An advisory committee plans to meet on Wednesday to decide on Sanofi's proposal to give the drug over-the-counter status.

View Full Article in:

Wall Street Journal (tiered subscription model), The · MedicalDaily.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN